Inspira Technologies Oxy B.H.N. Ltd.
$0.59
▲
6.21%
2026-04-21 07:28:01
inspira-technologies.com
NCM: IINN
Explore Inspira Technologies Oxy B.H.N. Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$21.71 M
Current Price
$0.59
52W High / Low
$1.65 / $0.34
Stock P/E
—
Book Value
$0.07
Dividend Yield
—
ROCE
-541.24%
ROE
-3.98%
Face Value
—
EPS
$-0.45
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
34
Beta
2.33
Debt / Equity
20.66
Current Ratio
1.56
Quick Ratio
1.3
Forward P/E
-0.61
Price / Sales
64.07
Enterprise Value
$15.84 M
EV / EBITDA
-1.18
EV / Revenue
54.8
Rating
None
Target Price
$5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 2. | TriSalus Life Sciences, Inc. | $4.6 | — | $285.58 M | — | -113.07% | 131.29% | $7.95 / $3.42 | $-0.68 |
| 3. | Alphatec Holdings, Inc. | $11.55 | — | $1.68 B | — | -10.13% | -6.31% | $23.29 / $9.89 | $0.08 |
| 4. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
| 5. | Biomerica, Inc. | $2.18 | — | $6.74 M | — | -122.16% | -84.3% | $4.6 / $1.87 | $1.5 |
| 6. | NovoCure Limited | $12.67 | — | $1.44 B | — | -26.47% | -38.89% | $20.06 / $9.82 | $3.03 |
| 7. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.29 M | 0 M | 0 M | 0 M |
| Operating Profit | -13.62 M | -11.27 M | -12.13 M | -14.89 M |
| Net Profit | -13.22 M | -11.05 M | -11.29 M | -14.98 M |
| EPS in Rs | -0.3 | -0.25 | -0.26 | -0.34 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.34 M | 8.07 M | 9.31 M | 16.17 M |
| Total Liabilities | 3.02 M | 3.75 M | 3.57 M | 2.54 M |
| Equity | 2.32 M | 4.32 M | 5.74 M | 13.63 M |
| Current Assets | 4.41 M | 6.81 M | 7.79 M | 14.49 M |
| Current Liabilities | 2.82 M | 3.37 M | 2.98 M | 1.66 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -9.86 M | -9.37 M | -9.69 M | -9.21 M |
| Investing CF | 0.56 M | 1.49 M | 4.59 M | -7.38 M |
| Financing CF | 7.33 M | 7.9 M | 3.45 M | 0 M |
| Free CF | -9.96 M | -9.54 M | -9.9 M | -9.47 M |
| Capex | -0.1 M | -0.16 M | -0.21 M | -0.26 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 2.06% | 24.64% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.